By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Dopaminergic antiparkinsonism agents > Rasagiline > Rasagiline Dosage
Dopaminergic antiparkinsonism agents
https://themeditary.com/dosage-information/rasagiline-dosage-6568.html

Rasagiline Dosage

Drug Detail:Rasagiline (Rasagiline [ ras-aj-il-een ])

Drug Class: Dopaminergic antiparkinsonism agents

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Parkinson's Disease

Monotherapy:
Recommended dose: 1 mg orally once a day

Adjunct therapy:
Initial dose (in patients on concomitant levodopa): 0.5 mg orally once a day
Initial dose (in patients not on concomitant levodopa): 1 mg orally once a day
Maintenance dose: 0.5 mg to 1 mg orally once a day

Maximum dose: 1 mg orally once a day

Comments: May be used as adjunct therapy in patients on levodopa therapy, with or without other drugs used in the treatment of Parkinson's disease.

Renal Dose Adjustments

Mild to Moderate Renal Dysfunction: No adjustment recommended
Severe Renal Dysfunction: Data not available

Liver Dose Adjustments

Mild Liver Dysfunction (Child-Pugh 5 to 6): 0.5 mg orally once a day
Moderate to Severe Liver Dysfunction (Child-Pugh 7 to 15): Use is not recommended

Dose Adjustments

Concomitant CYP450 1A2 inhibitors (e.g., ciprofloxacin): A dose of 0.5 mg orally once a day should not be exceeded.

When this drug is used in combination with levodopa, the levodopa dose may need to be reduced, according to clinical response.

Precautions

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • This drug may be taken with or without food

Monitoring:
  • Cardiovascular: Hypertension, postural/orthostatic hypotension
  • Dermatologic: Melanoma
  • Hepatic: Liver function
  • Musculoskeletal: Exacerbation of dyskinesia (if used concomitantly with levodopa)
  • Nervous system: Falling asleep during activities of daily living and somnolence, serotonin syndrome
  • Psychiatric: Suicidal ideation and behavior, falling asleep during activities of daily living and somnolence, re-emergence or worsening of symptoms of depression, impulse control disorders

General:
  • Rasagiline interacts with other drugs such as MAO inhibitors, meperidine (pethidine), potent CYP450 1A2 inhibitors, tramadol, St John's Wort, dextromethorphan, and methadone. Prescribers should be aware for the potential for interactions with rasagiline. A wash-out period may be required between ceasing rasagiline and commencing other medicines and vice versa.

Patient advice:
  • If you, your family member, or caregiver notice symptoms such as agitation, hostility, depression, thoughts about suicide or dying, or changes in thinking or behavior that are out of character, contact your health provider immediately.
  • Inform your health provider is you experience new or increased gambling urges, sexual urges, or other urges while taking this drug.
  • There is a potential for sedating effects associated with this drug, including somnolence and the possibility of falling asleep while engaged in activities of daily living. Avoid driving or operating heavy machinery until you know how this drug affects you.
  • Avoid foods containing a very large amount of tyramine (e.g., aged cheese) while taking recommended doses of this drug due to the potential to significantly increase blood pressure.
Share this Article
Latest News
Medical News

Seed oils: Omega-6 fatty acids may lower diabetes, heart disease risk

Jun 01, 2025
Type 2 diabetes: Sugary drinks may significantly raise risk
COVID-19: Who do the new vaccine guideline changes affect?
Vitamin D supplements may help slow down aging by 3 years
Aging: Exercise timing, consistency can affect heart and lung fitness
Heart health: Exercise not enough to offset effects of poor sleep
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by